Portfolio Update

BLACKROCK SMALLER COMPANIES TRUST PLC All information is at 30 SEPTEMBER 2012 and unaudited. Performance at month end is calculated on a capital only basis One Three One Three Five Month Months Year Years Years Net asset value 3.7% 7.2% 18.1% 70.1% 35.8% Share price* 3.2% 7.5% 16.7% 81.0% 36.0% Numis ex Inv Companies + AIM* 3.4% 7.4% 14.4% 25.7% -6.6% Sources: BlackRock and Datastream At month end Net asset value Capital only (debt at par value): 608.06p Net asset value Capital only (debt at fair value): 603.87p Net asset value incl. Income (debt at par value)**: 615.37p Net asset value incl. Income (debt at fair value)**: 611.18p Share price: 514.00p Discount to Cum Income NAV (debt at par value): 16.5% Discount to Cum Income NAV (debt at fair value): 15.9% Net yield: 1.6% Total assets^: £322.0m Net gearing incl. Income (debt at fair value): 10.0% 2012 Total Expense Ratio ("TER")^^: 0.7% Ordinary shares in issue#: 47,879,792 *without income reinvested **includes net revenue of 7.31p ^includes current year revenue ^^As reported in the Annual Financial Statements for the year ended 29 February 2012, the TER is calculated as a percentage of net assets and using operating expenses, excluding performance fees, finance costs and taxation. #excludes 2,113,731 shares held in treasury Ten Largest Sector Weightings % of total assets Support Services 9.4 Software & Computer Services 9.4 Oil & Gas Producers 7.4 Electronic & Electrical Equipment 7.3 Financial Services 6.1 Industrial Metals & Mining 5.8 Chemicals 5.7 General Retailers 5.4 Media 5.4 Pharmaceuticals & Biotechnology 5.2 ---- Total 67.1 ==== Ten Largest Equity Investments (in alphabetical order) Company Ashtead Aveva Group Bellway Booker Group Galliford Try Howden Joinery ITE Group Oxford Instruments Senior Victrex Commenting on the markets, Mike Prentis, representing the Investment Manager noted: During September, the NAV on a capital only basis rose by 3.7%; the benchmark rose by 3.4%. The FTSE 100 Index increased by 0.5% during the month. Gearing had a slightly positive impact on relative performance; neither stock selection nor sector allocation had much impact on relative performance during the month. There were no individually significant contributors to stock selection. We did however have strong results and trading updates from a number of larger holdings including Ashtead, Galliford Try and Hyder Consulting, and good meetings with many other holdings including Restaurant Group, Abcam, AZ Electronic Materials, Dunelm, Dechra Pharmaceuticals and Coastal Energy. We added small holdings in Entertainment One and Sinclair IS Pharma. Entertainment One is a leading international entertainment company specializing in the acquisition, production and distribution of film and television content across all media. It acquired Alliance Films, a similar but complementary business making the combined entity the largest independent film distributor in the UK and Canada, with considerable strength in many other key markets. We took part in an equity placing to part fund the purchase. Sinclair IS Pharma is an international specialty pharmaceutical company providing solutions to treat wounds, dermatological & oral diseases through advanced surface technology & innovative delivery systems. It has a growing sales and marketing operation in the UK and Continental Europe, and an extensive marketing partner network across selected developed & emerging markets which is generating strong sales growth. Management has impressed us and is beginning to achieve much better financial performance. 11 October 2012 ENDS Latest information is available by typing www.blackrock.co.uk/brsc on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings